(hubschmannMutationalMechanismsShaping2021b?)

Summary of novel genes

Entity Tier 1 genes Tier 2 genes
FL 2 15
DLBCL 3 23
--- config: sankey: showValues: true linkColor: target width: 600 height: 300 nodeAlignment: right prefix: '(' suffix: ' genes)' --- sankey-beta This study, New Tier 1, 3 New Tier 1, DLBCL Tier 1, 3 This study, New Tier 2, 23 New Tier 2, DLBCL Tier 2, 23 All other DLBCL studies, DLBCL Tier 1, 125 All other DLBCL studies, DLBCL Tier 2, 175

Novel genes reported in this study

Tier 1

New gene FL tier DLBCL tier
ACTG1 2 1
EEF1A1 1 1
FBXO11 1
VMA21 1

Tier 2

New gene FL tier DLBCL tier Average variant quality QC outcome
ADAMTS1 2 ★ ★ ★ ☆ ☆ Pass
ANKRD12 2 ★ ★ ★ ☆ ☆ Pass
ATP6V1A 2 ★ ★ ★ ★ ☆ Pass
CADPS2 2 ★ ★ ★ ★ ☆ Pass
CDC42BPB 2 ★ ★ ★ ☆ ☆ Pass
CNOT2 2 ★ ★ ★ ★ ☆ Pass
CPNE8 2 ★ ★ ★ ★ ☆ Pass
DHX15 2 ★ ★ ★ ★ ☆ Pass
DHX16 2 ★ ★ ★ ★ ☆ Pass
DNM2 2 ★ ★ ★ ☆ ☆ Pass
FZR1 2 ★ ★ ★ ☆ ☆ Pass
HLA-DQA1 2 ★ ★☆ ☆ ☆ Fail
IKBKE 2 ★ ★ ★ ★ ☆ Pass
IRF1 2 ★ ★ ★ ☆ ☆ Pass
JUP 2 ★ ★ ★ ★ ☆ Pass
LAPTM5 2 2 ★ ★ ★ ★ ☆ Pass
LRP12 2 ★ ★ ★ ☆ ☆ Pass
MGEA5 2 ★ ★ ★ ☆ ☆ Pass
MYCBP2 2 ★ ★ ★ ★ ☆ Pass
PDS5B 2 2 ★ ★ ★ ☆ ☆ Pass
PNPO 2 ★ ★ ★ ☆ ☆ Pass
PPP4C 2 ★ ★ ★ ★ ☆ Pass
PRKDC 2 2 ★ ★ ★ ☆ ☆ Pass
RAC2 2 ★ ★ ★ ☆ ☆ Pass
RBM6 2 ★ ★ ★ ☆ ☆ Pass
SIAH2 2 ★ ★ ★ ☆ ☆ Pass
SLC34A2 2 ★ ★ ★ ☆ ☆ Pass
TPP1 2 ★ ★ ★ ☆ ☆ Pass
TRAF6 2 ★ ★ ★ ☆ ☆ Pass
UNC5B 2 ★ ★ ★ ☆ ☆ Pass
WNK1 2 ★ ★ ★ ☆ ☆ Pass
ZNF217 2 ★ ★ ★ ☆ ☆ Pass
GAK 2 ★ ★ ☆ ☆ ☆ Fail
NR2F2 2 ★ ★ ☆ ☆ ☆ Fail

Details

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.